A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study

British Journal of Dermatology

Volumn 178, Issue 1, 2018, Pages e19-e21

  Lowe, A J ^a,b   Su, J C ^b,c   Allen, K J ^b   Abramson, M J ^c   Cranswick, N ^b   Robertson, C F ^b   Forster, D ^d,e   Varigos, G ^b   Hamilton, S ^a,b   Kennedy, R ^a,b   Axelrad, C ^b   Tang, M L K ^b   Dharmage, S C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CHOLESTEROL; EPICERAM; FATTY ACID; FOOD ALLERGEN; HISTAMINE; LIPID; SODIUM CHLORIDE; ALLERGEN; EMOLLIENT AGENT;

ATOPIC DERMATITIS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; CREAM; DRUG EFFECT; DRUG FORMULATION; DRUG SAFETY; EARLY INTERVENTION; EVIDENCE BASED PRACTICE; FAMILY HISTORY; FOLLOW UP; FOOD ALLERGY; GENETIC ASSOCIATION; HIGH RISK INFANT; HUMAN; HYDRATION; INCIDENCE; INFANT; INTENTION TO TREAT ANALYSIS; LETTER; MAJOR CLINICAL STUDY; MATERNITY WARD; MEDICATION COMPLIANCE; NEWBORN PERIOD; OUTCOME ASSESSMENT; PH; PHYSIOLOGICAL PROCESS; PILOT STUDY; PRICK TEST; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; SEBUM; SINGLE BLIND PROCEDURE; SKIN CARE; SKIN SENSITIZATION; SKIN SURFACE; SKIN WATER LOSS; TIME TO TREATMENT; CUTANEOUS DRUG ADMINISTRATION; DRUG ADMINISTRATION; DRUG COMBINATION; IMMUNOLOGY; NEWBORN; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ALLERGENS; CERAMIDES; CHOLESTEROL; DERMATITIS, ATOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; EMOLLIENTS; FATTY ACIDS; FOOD HYPERSENSITIVITY; HUMANS; INFANT; INFANT, NEWBORN; PILOT PROJECTS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 85034207954     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15747     Document Type: Letter

References (8)

1. Dharmage SC, Lowe AJ, Matheson MC et al. Atopic dermatitis and the atopic march revisited. Allergy 2014; 69:17–27.
2. Simpson EL, Chalmers JR, Hanifin JM et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 2014; 134:818–23.
3. Horimukai K, Morita K, Narita M et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 2014; 134:824–30.
4. Chamlin SL, Kao J, Frieden IJ et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47:198–208.
5. Jungersted JM, Scheer H, Mempel M et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 2010; 65:911–8.
6. Hachem JP, Crumrine D, Fluhr J et al. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003; 121:345–53.
7. Lee HJ, Yoon NY, Lee NR et al. Topical acidic cream prevents the development of atopic dermatitis- and asthma-like lesions in murine model. Exp Dermatol 2014; 23:736–41.
8. Lowe AJ, Tang ML, Dharmage SC et al. A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates. BMC Dermatol 2012; 12:3.